Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, PMV Pharmaceuticals Inc (NASDAQ: PMVP) closed at $1.32 down -2.22% from its previous closing price of $1.35. In other words, the price has decreased by -$2.22 from its previous closing price. On the day, 0.65 million shares were traded. PMVP stock price reached its highest trading level at $1.4 during the session, while it also had its lowest trading level at $1.3.
Ratios:
For a deeper understanding of PMV Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.52 and its Current Ratio is at 12.52. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 13, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.Jefferies initiated its Buy rating on April 12, 2024, with a $5 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 10 ’25 when ORBIMED ADVISORS LLC sold 500,000 shares for $1.80 per share. The transaction valued at 900,000 led to the insider holds 5,975,291 shares of the business.
OrbiMed Private Investments V, bought 2,283,654 shares of PMVP for $3,653,846 on Sep 10 ’25. On Jul 01 ’25, another insider, Ticktin Robert, who serves as the General Counsel & COO of the company, sold 23,151 shares for $1.06 each. As a result, the insider received 24,651 and left with 98,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 73127392 and an Enterprise Value of -71306056.
Stock Price History:
The Beta on a monthly basis for PMVP is 1.53, which has changed by -0.11409396 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, PMVP has reached a high of $1.84, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -6.59%, while the 200-Day Moving Average is calculated to be 5.28%.
Shares Statistics:
For the past three months, PMVP has traded an average of 1.11M shares per day and 499660 over the past ten days. A total of 52.99M shares are outstanding, with a floating share count of 45.24M. Insiders hold about 14.63% of the company’s shares, while institutions hold 65.14% stake in the company. Shares short for PMVP as of 1759190400 were 751556 with a Short Ratio of 0.68, compared to 1756425600 on 808829. Therefore, it implies a Short% of Shares Outstanding of 751556 and a Short% of Float of 1.67.
Earnings Estimates
The stock of PMV Pharmaceuticals Inc (PMVP) is currently in the spotlight, with 4.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.4 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.54 and -$1.62 for the fiscal current year, implying an average EPS of -$1.56. EPS for the following year is -$1.48, with 4.0 analysts recommending between -$0.97 and -$1.68.
